Largo Reports Q1 2025 Production and Sales Results; Provides Update on Operational Turnaround Plans By Investing.comApril 24, 2025
Moderna’s Investigational Vaccine for Respiratory Syncytial VirusBy topmanagerDecember 15, 20230 Moderna Inc. has reported significant progress in its efforts to combat respiratory syncytial virus (RSV), a notorious lower respiratory tract…
Moderna Unveils Promising Results from Cancer Treatment TrialBy topmanagerDecember 14, 20230 Moderna, in partnership with Merck, has released updated data from an ongoing early-stage trial of their innovative cancer treatment. The…